Chemokine receptor 5 and primary biliary cirrhosis: A two-centre genetic association study

Liver International

Volumn 24, Issue 6, 2004, Pages 646-650

  Baragiotta, A ^a,b   Floreani, A ^b   Agarwal, K ^a   Venturi, C ^b   Craggs, A ^a   Jones, D E J ^a   Donaldson, P T ^a   Bassendine, M F ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Candidate genes; CCR5; Genetic association; Primary biliary cirrhosis; Receptors

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CAUCASIAN; CELL TRANSPORT; CHRONIC LIVER DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HETEROZYGOTE; HUMAN; HYPOTHESIS; IMMUNOMODULATION; INFLAMMATION; INTERNATIONAL COOPERATION; INTERNET; ITALY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIMARY BILIARY CIRRHOSIS; PROTEIN EXPRESSION; PUBLICATION; T LYMPHOCYTE; UNITED KINGDOM;

BASE SEQUENCE; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; GREAT BRITAIN; HUMANS; ITALY; LIVER CIRRHOSIS, BILIARY; MALE; MOLECULAR SEQUENCE DATA; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROBABILITY; RECEPTORS, CCR5; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 11144267993     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.0980.x     Document Type: Article

References (30)

1. Bassendine M F. The molecular basis of primary biliary cirrhosis. In: Trauner M, Jansen P L M, eds. Molecular Pathogenesis of Cholestasis. Landes Bioscience, Plenum Publishers 2004; 221-46.
2. Jones D E J, Donaldson P T. Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin Liver Dis 2003; 7: 841-64.
3. Jones D E, Watt F E, Metcalf J V, Bassendine M F, James O F W Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 1999; 30: 402-7.
4. Selmi C, Mayo M J, Bach N, et al. Occurrence of primary biliary cirrhosis in monozygotic twins. Hepatology 2002; 36: 387A.
5. Kaplan M M, Rabson A R, Lee Y M, Williams D L, Montaperto PA. Discordant occurence of primary biliary cirrhosis in monozygotic twins. N Engl J Med 1994; 331: 952.
6. Prince M I, Chetwynd A, Diggle P, Jarner M, Metcalf J V, James O F. The geographical distribution of primary biliary cirrhosis is a well-defined cohort. Hepatology 2001; 34: 1083-8.
7. Haydon G H, Neuberger J. PBC: an infectious disease? Gut 2000; 47: 586-8.
8. Xu L, Sakalian M, Shen Z, Loss G, Neuberger J, Mason A. Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. Hepatology 2004; 39: 151-6.
9. Klein R, Wiebel M, Engelhart S, Berg PA. Sera from patients with tuberculosis recognise the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis. Clin Exp Immunol 1993; 92: 308-16.
10. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-8.
11. Lalor P F, Shields P, Grant A, Adams D H. Recruitment of lymphocytes to the human liver. Immunol Cell Biol 2003; 80: 52-64.
12. Carvalho-Pinto C, Garcia M I, Gomez L, Ballesteros A, Zaballos A, Flores J M, et al. Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice. Eur J Immunol 2004; 34: 548-57.
13. Yun J J, Whiting D, Fischbein M P, Banerji A, Irie Y, Stein D, et al. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection. Circulation 2004; 109: 932-7.
14. Venkatesan S, Petrovic A, Van Ryk D I, Locati M, Weissman D, Murphy P M. Reduced cell surface expression of CCR5 in CCR5De1ta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration. J Biol Chem 2002; 277: 2287-301.
15. Liao H X, Montefiori D C, Patel D D, Lee D M, Scott W K, Pericak-Vance M, et al. Linkage of the CCR5 Delta 32 mutation with a functional polymorphism of CD45RA. J Immunol 2000; 165: 148-57.
16. Leon M P, Spickett G, Jones D E J, Bassendine M F. CD4+T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis. Clin Exp Immunol 1995; 99: 233-9.
17. Musialik J, Michalkiewicz J, Petelenz M, Mazurek U, Mazur W, Madalinski K, et al. Reduction of CD45RA isoform expression and decrease in CD4 and CD8 receptor density in lymphocytes of patients with primary biliary cirrhosis. Scand J Gastroenterol 2003; 38: 421-6.
18. Feld J J, Heathcote E J. Epidemiology of autoimmune liver disease. J Gastroenterol Hepatol 2003; 18: 1118-28.
19. Limborska S A, Balanovsky O P, Balanovskaya E V, Slominsky P A, Schadrina M I, Livshits L A, et al. Analysis of CCR5Delta32 geographic distribution and its correlation with climatic and geographic factors. Hum Hered 2002; 53: 49-54.
20. Ioannidis J P, Rosenberg P S, Goedert J J, Ashton L J, Benfield T L, Buchbinder S P, et al. Effects of CCR5-Delta32, CCR2-641, and SDF-1 3′ A alleles in HIV-1 disease progression: an international meta-analysis of individual patient data. Ann Intern Med 2001; 135: 782-95.
21. Ashton L J, Stewart G J, Biti R, Law M, Cooper D A, Kaldor J M. Heterozygosity for CCR5-Delta32 but not CCR2b-641 protects against certain intracellular pathogens. HIV Med 2002; 3: 91-6.
22. Barcellos L F, Schito A M, Rimmler J B, Vittinghoff E, Shih A, Linclon R, et al. CC-chemokine receptor 5 polymorphism and age onset in familial multiple sclerosis. Immunogenetics 2000; 51: 281-8.
23. Moench C, Uhrig A, Lohse A W, Otto G. CC chemokine receptor 5delta32 polymorphism - a risk factor for ischemic-type biliary lesions following orthotopic liver transplantation. Liver Transplant 2004; 10: 434-9.
24. Ueda H, Howson J M, Esposito L, Heward J, Snook H, Chamberlain G, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-11.
25. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996; 85: 311-8.
26. Anonymous. Freely associating. Nat Genet 1999; 22: 1-2.
27. Matsushita M, Miyakawa H, Tanaka A, Hijikata M, Kikuchi K, Fujikawa H, et al. Single nucleotide polymorphisms of the mannose-binding lectin are associated with susceptibility to primary biliary cirrhosis. J Autoimmunity 2001; 17: 251-7.
28. Pauli-Magnus C, Kerb R, Fattinger K. Lang T, Anwald B, Kullak-Ublick G A, Beuers U, Meier P J. BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhsosis and primary sclerosing cholangitis. Hepatology 2004; 39: 779-91.
29. Donaldson P T. TNF polymorphisms in PBC: a critical approach. J Hepatol 1999; 31: 355-68.
30. Colhoun H M, McKeigue P M. Smith G D. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 865-72.